14.JPG)
The Bowel Management Systems Market Size is valued at USD 2.19 Billion in 2023 and is predicted to reach USD 3.02 Billion by the year 2031 at a 4.24 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The advent of this market arose for patient-centered care, empowering individuals to manage their bowel-related symptoms and improve their overall well-being effectively.
- The increasing prevalence of chronic bowel disorders like IBD and IBS is expected to drive industry growth.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
Bowel management systems control the containment of liquid or semi-liquid stools. It is applied to people with fecal incontinence to protect their skin from pollutants and moisture that could lead to skin damage. Containing infected body waste in a closed system decreases the spread of infection. Furthermore, it offers protection by supporting the sacral and perianal pressure points. The chance of unintentional stool leakage and constipation can be greatly reduced by using bowel management systems or devices such as colostomy bags, irrigation systems, and others. Due mainly to the availability of technologically cutting-edge bowel management devices, the market for bowel management systems is anticipated to rise significantly throughout the forecast period.
Additionally, the market is growing due to the ageing population and an increase in diseases like irritable bowel syndrome linked to fecal irregularity. Irritable bowel syndrome incidence has markedly increased in recent years, with reports from around the world. For instance, the American College of Gastroenterology estimates that between 10% and 15% of adults in the U.S. experience symptoms of IBS.
However, a surge in government R&D expenditures in the healthcare industry fuels the market for bowel management systems. The market isn't growing, though, because there aren't enough qualified specialists and patients find these gadgets uncomfortable to use. Contrarily, it is anticipated that developing healthcare R&D facilities and introducing numerous new devices would open up lucrative chances to expand the bowel management system market.
Competitive Landscape
Some major key players in the Bowel Management Systems Market:
- Axonics Inc.,
- Becton, Dickinson and Company,
- Braun Melsungen AG,
- Coloplast Group,
- ConvaTec Group, plc,
- Consure Medical,
- Hollister Incorporated,
- Laborie Medical Technologies, Corp.,
- ProSys International Ltd.,
- Renew Medical, Inc.,
- Welland Medical Limited,
- Qufora A/S,
- Medtronic,
- Wellspect HealthCare
- TG Eakin.
Market Segmentation:
The bowel management systems market is segmented by product, patient type and end user. Based on the product, the market is segmented into systems (colostomy bags, irrigation systems, sacral neuromodulation systems and others) and accessories (plugs, catheters, implants, anal sphincters, stool bags and others). Based on the patient type, the market is segmented into adult and pediatric. Based on the end user, the market is segmented into hospitals, ambulatory surgical centres and home care settings.
Based On The Product, The System Category Is Accounted As A Major Contributor To The Bowel Management Systems Market.
The system category dominated the market in 2021 because more complex bowel management methods are being approved. For instance, in 2020, the U.S. FDA approved Medtronic's InterStim Micro neurostimulator, and InterStim SureScan MRI leads to treating bladder and bowel control issues. Colostomy bags, a subsection of the system category, have a more significant share than the others; nevertheless, people are becoming more aware of their availability and advantages. Additionally, it is predicted that the market will grow throughout the projection period due to developed regions having well-organized reimbursement systems for colostomy goods. However, government entities in developed areas are introducing programs to support people with stomas by enhancing access to the most suitable and therapeutically relevant stoma-related products.
The Adult Category Witnessed Growth At A Rapid Rate.
The adult category dominated the market in 2021 because adult people are more likely to experience fecal irregularity problems. Additionally, elderly persons require additional aid and consideration when managing consistency. Therefore, increasing the world's older population supports the market's expansion. It affects roughly 1 in 12 adults, or 18 million people, in the United States, making it a common illness among adults.
The North American Bowel Management Systems Market Holds A Signification Revenue Share.
The North American bowel management systems market is expected to register the highest market share. The considerable rise in the number of older adults in this area accounts for this. The dominance of the United States in the North American market is expected to remain constant over the projection period. Irritable bowel syndrome is more common in this area, which is the cause of this. For instance, the International Foundation for Gastrointestinal Disorders estimates that 25 and 45 million Americans suffer from IBS. Additionally, a key trend in the North American market for bowel management systems is ongoing R&D for creating cutting-edge bowel management devices for fecal management. The increase in older adults in this area also helps the industry flourish. In addition, Asia Pacific is projected to grow rapidly in the global bowel management systems market due to rising healthcare infrastructure demand, an increase in hospitals in developing nations, rapid R&D sector expansion, a rise in healthcare reforms, and technical developments in the industry. Additionally, the market is expected to be driven by the enormous unmet clinical needs and the urgent need for better therapy.
Recent Developments:
- In April 2022, Microbiotica secured project funding from the Crohn's and Colitis Foundation through their inflammatory bowel disease ventures program. This funding aims to support the development of therapies specifically designed to treat inflammatory bowel disease.
- In February 2022, Coloplast introduced the SenSura Mio in Singapore, aiming to enhance the quality of life for individuals with ostomies who are managing a stoma.
Bowel Management Systems Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.19 Billion |
|
Revenue Forecast In 2031 |
USD 3.02 Billion |
|
Growth Rate CAGR |
CAGR of 4.24 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Product, Patient Type, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Axonics Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Coloplast Group, ConvaTec Group, plc, Consure Medical, Hollister Incorporated, Laborie Medical Technologies, Corp., ProSys International Ltd., Renew Medical, Inc., Welland Medical Limited, Qufora A/S, Medtronic, Wellspect HealthCare and TG Eakin. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
